← Leaderboards
Anna Philip Kovilakath
Virginia Commonwealth University
$119,095
Attributed
$119,095
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40.6K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$119,095 · 1
By mechanism
F31$119,095 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Fadi N Salloum$8,358,104
- William Gregory Hundley$19,718,962
- Zhibing Zhang$4,406,150
- Sarah Spiegel$20,919,449
- Briana James$53,436
Others in their field
Other Emerging Leaders on “Dihydrosphingosine”
- Pedro Filipe Da Costa Pinheiro · University Of Virginia$381,486
Research focus
DihydrosphingosineAffectAnabolismApoptoticAutophagocytosisAnterior Descending Coronary ArteryApoptosisBiologicalBrain Hypoxia-IschemiaCandidate MarkerCardiacCardiac MyocytesCardiovascular HealthCause Of DeathCell DeathBindingCell NucleusCeramidesCessation Of LifeCoenzyme ACohortComplexCytoplasmDihydrosphingosine 1-Phosphate
Grant awards (3)
Sptlc3-derived sphingolipids in cardiomyocyte death in ischemia$40,565
F31 · FY2023 · HL · contact PI
Sptlc3-derived sphingolipids in cardiomyocyte death in ischemia$39,623
F31 · FY2022 · HL · contact PI
Sptlc3-derived sphingolipids in cardiomyocyte death in ischemia$38,907
F31 · FY2021 · HL · contact PI